Outsourcing in Clinical Trials Southern California 2023

Arena International are delighted to announce the Outsourcing in Clinical Trials Southern California Event will be returning to California's La Jolla on September 26th & 27th 2023!

26 - 27

September

2023
  • Hyatt Regency La Jolla at Aventine, USA
  • Complimentary

Why attend?

A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES

As this event returns you can expect high level discussion and presentations with industry thought leaders focusing on novel and innovative solutions to some of this years key challenges. Additionally with our technology and innovation stream, learn what is in store for the future of clinical trials.

450+

ATTENDEES

65+

EXHIBITORS

30+

SPEAKERS

50%

ATTENDEES AT DIRECTOR + LEVEL

450+

ATTENDEES

65+

EXHIBITORS

30+

SPEAKERS

50%

ATTENDEES AT DIRECTOR + LEVEL

See What It's All About

Agenda

  • 26 Sep 2023
  • 27 Sep 2023
Expand All

Streams

Stream one

Outsourcing & Clinical Operations

Stream two

Clinical Trial Technology & Innovation

7:45 AM

Registration and Refreshments

8:20 AM

Chair’s Opening Remarks

8:30 AM

KEYNOTE PANEL Patient engagement – What we as an industry need to do to promote trust

  • How other experts are boosting engagement across therapeutic indications
  • Talking the good, the bad and the ugly of recruitment
  • Discussing innovative patient recruitment tools being used in the industry

Speakers

9 AM

Session Reserved for Novotech

9:30 AM

Oversight of clinical studies in India & Eastern Europe

  • What are the main hurdles to overcome to run a trial here
  • Balancing the cost efficiency of running trials here with the extra work needed to ensure good clinical quality data
  • Managing compliance in the region

10 AM

Morning Refreshments and Networking

10:45 AM

What is your competitive secret sauce – a talk from an expert sharing tips to speed up trials

  • Competitive clinical operations, being the best you can be
  • Risk mitigation and vendor management?
  • How quickly can you activate your sites?
  • How do you reduce your risks

Speakers

11:30 AM

Session Reserved for PCM Trials

12 PM

Finding CROs and partners as a small to medium sized company: challenges and considerations

  • Finding the right match for your specific indication
  • The do’s and don’ts of who to work with as a small biotech
  • Discussing how to enter contract negotiation on the right footing

Speakers

12:30 PM

Session Reserved for TFS Health Science

1 PM

Lunch and Networking

Lunch and Networking 

JOIN ONE OF OUR NETWORKING TABLES

Eat lunch with a like-minded group of industry colleagues by joining one of our lunchtime discussion groups on the topics below:

TABLE 1: Patient enrollment, what are we doing to improve uptake in new trials. TABLE 3: Managing your trial budget during uncertain times.
TABLE 2: Finding the right CRO for your study. TABLE 4: Decentralization, for or against?

2 PM

PANEL DISCUSSION – Top tips and tricks for managing your trial budget during unstable times

  • Understanding what the reality of the costs of clinical trials are and what could happen to increase costs
  • Planning out the entire trial with a budget focus, what steps are truly needed
  • Everyone is undergoing cost savings, what are key areas to cut down in

Speakers

2:30 PM

Feeling Pressure to Curb Costs? How Central Monitoring Can Stretch Your Budget Without Compromising Quality

  • Considerations for implementing a successful central monitoring strategy
  • The value proposition: Where central monitoring can have the greatest impact for reducing clinical trial costs
  • How central monitoring may impact the future role of the CRA

3 PM

Working alongside your finance team from the clinical side to make your budget go further

  • Handling the funding issues of newer trials in an unpredictable economy
  • Tips and tricks for small and medium pharma to work alongside your financial team
  • Discussing alternative financing methods rather than compromise the quality of your trials
  • Design changes to incorporate early in your study cycle to reduce costs

Speakers

3:30 PM

Afternoon Refreshments and Networking

4 PM

Navigating the perfect storm as a small biotech company: what you need to know to succeed

  • How macro-political and economic issues affect clinical trials and mitigating risk surrounding this
  • Cutting costs and maximizing resources: the financial consequences of the storm on small biotech organizations
  • Understanding the changing regulatory environment for trials in 2023
  • Keeping the patient at the center of changes to clinical trials: navigating the storm while minimizing patient impact

Speakers

4:30 PM

Is Outsourcing Clinical Trials with Multiple Consultants Right for My Company? Balancing the Tradeoffs vs a Full Service CRO

  • Fostering co-operation between different vendors on one clinical study
  • How to manage the tradeoffs of multiple consultants against the use of a full service strategy

Speakers

5 PM

Chair’s Summation and Drinks Reception

10:45 AM

PANEL DISCUSSION – Evaluating the use of modern technology in clinical trials in a post-COVID landscape

  • Are we better off now with technology or were we better off before
  • What useful changes have we received since the pandemic
  • What is here to stay and what should be left behind?

Speakers

11:30 AM

Optimizing early development to maximize success probability in the late stage development

  • Dose escalation: Critical elements to support informative drug safety profile and initial efficacy
  • Selection of the dose for the late-stage development: decisions around monotherapy, combination regimens
  • Incorporation of the patient voice, alignment with medical quality measures, considerations around existing treatment options landscape

Speakers

12 PM

Dealing with Phase 3 data challenges; how to get data collection back on track

  • Handling adversity when challenges arise in your study
  • Highlighting the value of hands-on experience when managing a complex study
  • How to negotiate with a partner after issues have arisen, getting your money’s worth
  • Lessons learned when managing large data sets
  • Advice for future trials, how to ensure data collection and quality is on point

Speakers

12:30 PM

15 Minute Tech Spotlight by eClinical Solutions

  • 15 Minute Tech Spotlight by IQVIA

1 PM

Lunch and Networking

  • JOIN ONE OF OUR NETWORKING TABLES

    Eat lunch with a like-minded group of industry colleagues by joining one of our lunchtime discussion groups on the topics below:

    TABLE 1: Patient enrollment, what are we doing to improve uptake in new trials. TABLE 3: Managing your trial budget during uncertain times.
    TABLE 2: Finding the right CRO for your study. TABLE 4: Decentralization, for or against?

Speakers

2 PM

The upcoming importance of diversity in clinical trials And how it can promote patient recruitment

  • A look into the new requirements made by the FDA and what you need to be aware of
  • How to most efficiently enrol the right patients needed for your trial to be approved
  • Looking at all aspects of diversity and why they are important for clinical trials

Speakers

2:30 PM

Session Reserved for YPrime

3 PM

Interactive Workshop – Exploring the use of innovative technologies in clinical studies

  • Understanding the benefits and challenges of using newer technologies such as AI in clinical studies.
  • Discussing the factors to consider when deciding whether to implement emerging technologies in clinical studies.
  • Identifying the potential use cases of innovative technologies in clinical trials, and how they can improve study outcomes.

Speakers

12:30 PM

Lunch and Networking

  • JOIN ONE OF OUR NETWORKING TABLES
  • Eat lunch with a like-minded group of industry colleagues by joining one of our lunchtime discussion groups on the topics below:
  • TABLE 1: Innovative ways of improving CRO engagement and communication TABLE 3: Exploring best practices for conducting international trials in a post-pandemic world
  • TABLE 2: Overcoming common small company pain points TABLE 4: What does ‘patient-centricity’ mean to you?

3:30 PM

Afternoon Refreshments and Networking

4:30 PM

AUDIENCE Q+A A playbook for how to handle an undesirable CRO-sponsor partnership & how to turn it around

  • Is it worth tweaking the relationship? How do you know when/how to severe ties? This session will consist of a quick 15min presentation followed by audience Q&A
  • Utilizing milestone data to identify if the CRO-sponsor partnership is efficient and successful
  • Renegotiate – pros and cons of tweaking the CRO relationship compared to cutting ties, particularly in niche areas
  • Don’t burn bridges – identifying when to bail and how to go about it with grace
  • Exploring exactly why the CRO isn’t hitting those milestones and what can be changed

5 PM

Chair’s Summation and Drinks Reception

Streams

Stream one

Outsourcing & Clinical Operations

Stream two

Clinical Trial Technology & Innovation

7:50 AM

Registration and Refreshments

8:25 AM

Chair’s Opening Remarks

8:30 AM

Mining for Gold: Looking at trends and budget analysis to find cost savings

  • How to monitor and record cost savings in a clinical stage business
  • Proving your net worth through your negotiations
  • Finding savings in hidden places

Speakers

9 AM

Session Reserved for Event Sponsor

9:30 AM

PANEL DISCUSSION Talking through vendor management tips and tricks

  • Tips to manage your relationship with your CRO
  • Working with new staff turnover and how to maintain high data quality
  • A refresher on metrics and KPIs, how we analyze our partnerships with CROs
  • How to maintain a positive relationship with your CRO.

Speakers

10 AM

Session Reserved for Event Sponsor

10:30 AM

Morning Refreshments and Networking

11 AM

PANEL DISCUSSION – Working closely with your site to achieve a mutually beneficial relationship

  • How to curate a positive relationship with your site
  • Data collection in sites –what can you do as a sponsor to bring it back up to speed?
  • What lessons have we learnt when moving in and out the clinic, a reflection from the past few years
  • How to make your IMP stand out amongst the crowd

Speakers

11:45 AM

Session Reserved for Event Sponsor

12:15 PM

How do you build your clinical team – people leadership development

  • How to train your team as future leaders from the beginning
  • How we as an industry can work together to develop the next generation of leaders

Speakers

12:45 PM

Lunch and Networking

1:45 PM

PANEL DISCUSSION – What are the lessons learned from decentralizing – what takeaways do we have as an industry from the last few years

  • Weighing the advantages and disadvantages of having decentralized
  • What do both the sponsor and vendor want to gain from decentralizing trials and how can we balance that
  • Look at the real costs of DCT, does it impact your data quality

Speakers

2:15 PM

The journey of Drug Product from Manufacturing to Clinical Administration

  • Challenges of Supply chain logistics across the globe with different biologics
  • Selecting Storage and Supply Depot across the globe
  • Robustness around Clinical in-use study design and Clinical administration

Speakers

2:45 PM

Afternoon Refreshments and Networking; Apple Prize Draw

3:15 PM

Speaker Hosted Roundtables

  •  Speaker Hosted Roundtables

    Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

    Each roundtable session lasts for 30 minutes, and delegates may attend up to 2 roundtables

    RT 1 Talking all things study design, how to have a clear end point when designing your study

    Joseph Shan, Executive Director, Clinical Development Operations, MEI Pharma

    RT 2 Managing CRO relationships, what we are doing to work with our future partners.

    Kerry Clancy, Director of Outsourcing, AnaptysBio

    RT 3 The state of current biotech financing: navigating uncertain times

    Peter B. Heifetz, President and CEO, OrPro Therapeutics

4:15 PM

Close of conference

8:30 AM

MDR – a deep dive into the complexity of the problem

  • How Did We Get Here and is it Really Fixing the Problem?
  • What Happens to Innovation
  • Unintended Consequences: Long Term and Short Term Downstream Effects
  • Who are the Winners and Losers?
  • Where are we Now and What to Expect Next

Speakers

9 AM

Hybrid trials using DCT technology and processes; focus on patients and the sites

  • Highlighting the complexity that Hybrid/DCT brings whilst moving away from the common brick-and-mortar sites.
  • Discussing the rise in regulator concerns in areas such as investigator oversight, and participant’s safety when face to face contact is limited.
  • How we tend to focus too much on technology when it’s actually the processes for the patients and the sites that matter even more.
  • Major points to consider in designing hybrid/DCT trials; building blocks and practical examples to best prepare you to meet the needs of regulators whilst keeping the patient and sites front of mind.Sverre Bengtsson

Speakers

9:30 AM

IVD, Combining the regulatory & clinical strategy to improve clinical trial outcome

  • General regulatory strategy to consider when planning your clinical trials
  • Cross functional work between the regulatory and clinical teams to achieve a strong regulatory submission package
  • Key global IVD clinical regulatory changes to take note of in the coming years

Speakers

10 AM

Session Reserved for Event Sponsor

10:30 AM

Morning Refreshments and Networking

11 AM

Modern issues with sample and data reconciliation and how to get around them

  • Relationship with site and your central lab
  • Between labs, working with central and focused analytical labs
  • Managing your data post analytics

Speakers

11:45 AM

Session Reserved for Event Sponsor

12:15 PM

Precision clinical trials in the era of big data, artificial intelligence, and precision medicine

  • Exploring the innovations in modern clinical trials that have made a difference in precision medicine.
  • In the modernising world of AI how much impact can we expect that to have on clinical trials.
  • Identifying the future of Precision trials and highlighting the big players in the fie

Speakers

12:45 PM

Lunch and Networking

Speakers

Select a speaker to learn more

Back
Jennifer Lee
Senior Vice President Of Clinical Operation, Biostats, And Data Management , Elevar Therapeutics

Jennifer Lee is Senior Vice President of Clinical Operation, Biostats, and Data Management at Elevar Therapeutics. Jennifer brings over 25 years of industry expertise in clinical strategies, asset evaluation, and advancing novel and innovative clinical programs spanning phases I-IV across therapeutic areas, including oncology, infectious disease, inflammation, urology, CNS, cardiovascular, rare disease, and stem and cell therapies.

She is an invited speaker at international conferences and has successfully submitted market applications leading to seven NDA approvals. Previously, Jennifer worked at G.D. Searle, Pharmacia, Pfizer, Astellas Gilead Sciences, and other mid- and micro-cap companies.

Jennifer holds a BS in Biochemistry from the University of Illinois and an MS in Clinical Research and Regulatory Administrations from Northwestern University. She is an active mentor, Women in Bio supporter, and board member.

Session Details:

What is your competitive secret sauce – a talk from an expert sharing tips to speed up trials

2023-09-26, 10:45 AM

View In Agenda
Next speaker
Back
Roger Davies
Vice President Operations

Session Details:

PANEL DISCUSSION – Working closely with your site to achieve a mutually beneficial relationship

2023-09-27, 11:00 AM

View In Agenda
Next speaker
Back
Betsey Zbyszynski
Director, Clinical Contracts & Outsourcing

Betsey has been in clinical research industry for 25 years with a focus of responsibility in clinical operations, outsourcing and strategic planning.  Betsey has extensive experience managing vendors, client relationships, identifying and mitigating risks as well as negotiating contracts and budgets.  She has worked in both the pharma and CRO sectors.

Session Details:

PANEL DISCUSSION – Top tips and tricks for managing your trial budget during unstable times

2023-09-26, 2:00 PM

Session Details:

PANEL DISCUSSION Talking through vendor management tips and tricks

2023-09-27, 9:30 AM

View In Agenda
Next speaker
Back
Maribelle Guloy
Director, Clinical Development, HBT LABS - A Wholly Owned Subsidiary of American Regent

Maribelle Guloy is the Director of Clinical Development at American Regent, A Daiichi Sankyo company, where she is responsible for the development of clinical trial protocol design and strategic direction and execution of a clinical program.

Maribelle is a member of the Advisory Board in Clinical Trials: Medical Device & Drug Development at University of California, Irvine. Maribelle was previously a member of the Board of Directors at the Society of Clinical Research Associates (SoCRA) and continues to serve as its Chairperson in Orange County, California

Next speaker
Back
Kenneth Kleinhenz
COO, Lorem Cytori, USA

Kenneth Kleinhenzhas held numerous executive-level quality assurance and regulatory affairs position at public and private biotechnology companies to include 15 years of service as the Vice President and Chief Operating Officer at Cytori Therapeutics, a device-based, adipose-focused stem cell company. Previously, Mr. Kleinhenz was the Vice President of Quality and Regulatory at Avelas Biosciences, Director of Regulatory Affairs at MacroPoreBiosurgery, Chief Microbiologist for Becton Dickinson, and theManager of Quality Assurance and Regulatory Affairs at Pacific Pharmaceuticals. Mr. Kleinhenz is a veteran of the United States Navy where he served as a Clinical Microbiologist for 6 years at the NavalHospital, San Diego. Mr. Kleinhenzreceived his BS in Microbiology at the University of California, San Diego (UCSD) and his MBA in Technology Management at the University of Phoenix.

Session Details:

MDR – a deep dive into the complexity of the problem

2023-09-27, 8:30 AM

View In Agenda
Next speaker
Back
Saeid Yazdani
Vice President Portfolio Management - Therapeutics Product Development

Saeid Yazdani serves as the Vice President of Program Management for Caribou Biosciences. He brings over 30 years of Program & Portfolio leadership experience from therapeutic discovery to commercialization, working with cross-functional leaders in research, development, operations, CMC, clinical, regulatory, quality, commercial, and executive team. Previously, he was Vice President of Therapeutics Program Management at Huyabio International, during which time he led two IND approval and oversaw six therapeutics development programs. He is an entrepreneur and inventor with U.S. patents. Saeid has held a variety of leadership, business, and program & portfolio positions of increasing responsibility at Thermo Fisher, Nestle Health Science, Merck (EMD), Genentech, Gilead, and Synergic Analytics, and adjunct professor at the University of California, San Diego extended studies. Saeid holds a B.S. in Chemistry from Western Michigan University & MBA from the University of Southern California.

Session Details:

How do you build your clinical team – people leadership development

2023-09-27, 12:15 PM

View In Agenda
Next speaker
Back
Amish Patel
VP of Technical Operations

Dr. Amish Patel has over 18 years of leadership experience in global biopharma and biotech industry, providing strategic guidance throughout the entire biologic product life-cycle.  Dr. Patel is responsible for critical oversight of Global Manufacturing, Quality Control, Quality Assurance and Supply Chain to produce Clinical and Commercial cancer therapies utilizing Calidi’s innovative oncolytic viral therapies with stem cell-based delivery platforms to treat a wide range of cancers with significant unmet needs.

Over the course of his career, he has led the development of over fifteen INDs, two commercial product approvals, and numerous PAS submissions. He was most recently, the Senior Director of Product Development at Emergent BioSolutions (formerly PaxVax, Inc., prior to acquisition), where he successfully built and directed cross-functional teams working on numerous biologic Clinical products.

Session Details:

The journey of Drug Product from Manufacturing to Clinical Administration

2023-09-27, 2:15 PM

View In Agenda
Next speaker
Back
Peter B. Heifetz
President And CEO, OrPro Therapeutics
Next speaker
Back
Sormeh Mahjouri, MPH, PMP
Program Director

Sormeh is currently Program Director at local biotech start-up in cancer imaging, Imagion Biosystems. She has previous experience in Program Management, Clinical Operations, and Regulatory Affairs and has worked in the biopharma/medical device industries for over 12 years (Arena Pharmaceuticals – recently acquired by Pfizer, Gilead, Medtronic).

Session Details:

PANEL DISCUSSION Talking through vendor management tips and tricks

2023-09-27, 9:30 AM

View In Agenda
Next speaker
Back
Rupesh Kanchi Ravi
Head, Pfizer Oncology Clinical Research Lab

Rupesh Kanchi Ravi is the Lab Head in the Pfizer Oncology Clinical Research Laboratory (POCRL), a clinical genomics GCLP lab overseeing Pfizer Oncology custom genomics clinical sample testing and new platform evaluations for genomics biomarker strategy and clinical utility working with CROs. Previously, Rupesh held the role of Biomarker Assay Specialist as clinical genomics and NGS expertise managing clinical NGS testing for Translational Oncology Phase 1 study programs and working with cross-functional teams that included GPD Oncology, ECD, and Computational Biology.

Prior to joining Pfizer Oncology, Rupesh held senior scientist positions at Genoptix, UCSD’s Genomics Center, TGen in which he developed, validated, and launched novel NGS assays (cfDNA, targeted DNA, targeted RNA, exosomal RNA, miRNA) for GCLP and CAP/CLIA lab environments, and developed novel NGS library generation techniques for numerous nucleic acid sample types. Rupesh earned his PhD in Biotechnology at Pondicherry University where he studied the anti-inflammatory and anti-cancer properties of marine natural products. He received his first postdoctoral training at the French National Center for Scientific Research (CNRS) in the Extreme Environments Microbiology Lab where he characterized the DNA replication/repair machinery of hyperthermophiles. He received his second postdoctoral training at University of Arizona where he identified novel alternate DNA repair pathway Base Excision Repair pathway inHSV-1 and developed a High Thorough put assay for identifying single strand DNA-protein inhibitors.

Session Details:

Modern issues with sample and data reconciliation and how to get around them

2023-09-27, 11:00 AM

View In Agenda
Next speaker
Back
Majid Ghoddusi
Senior Director, Clinical Biomarkers, Poseida Therapeutics

Majid joined Janux in June 2022 as executive director and head of clinical biomarkers responsible to devise strategy, source best technology and platforms and execute comprehensive laboratory testing plans in support of Janux clinical studies.  Majid has over 15 years of experience in some of the most challenging areas of oncology therapeutics with a primary focus on predictive oncology clinical development. Trained as a translational pathologist he has held impactful positions with increasing responsibilities at large pharmaceutical and small to medium biotech companies including Novartis, Celgene, Juno Therapeutics, Five Prime, and Poseida Therapeutics.

 

Majid has a Doctor of Veterinary Medicine degree, a postgraduate diploma and a PhD from the University of Queensland in Australia.

Session Details:

PANEL DISCUSSION – Evaluating the use of modern technology in clinical trials in a post-COVID landscape

2023-09-26, 10:45 AM

View In Agenda
Next speaker
Back
Anusha Perera
Senior Director, IT

Experienced IT leader specializing in clinical technology, adept at launching programs that safeguard data, streamline operations, drive innovation, and advance business strategy within the healthcare industry. Well-versed in clinical systems, electronic health records, medical device integration, data analytics, and regulatory compliance, ensuring efficient and effective patient care delivery.

Session Details:

PANEL DISCUSSION – Evaluating the use of modern technology in clinical trials in a post-COVID landscape

2023-09-26, 10:45 AM

View In Agenda
Next speaker
Back
AJ Bergmann
Chief Financial Officer, Capricor Therapeutics

AJ Bergmann is currently the Chief Financial Officer of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Mr. Bergmann joined Capricor in 2011 and he also serves as the Company’s corporate treasurer. During his time at Capricor, Mr. Bergmann directly coordinated the Company’s reverse merger and subsequent uplisting to the NASDAQ and financings yielding over $100.0 million, to date. He has experience in developing corporate and financial strategy alternatives and executing strategic plans. Mr. Bergmann manages the Company’s finance, accounting, business development, and human resource functions. Prior to joining Capricor, Mr. Bergmann had experience in accounting, finance, and operations management of companies ranging in size from start-ups to mid-size companies. Most recently he was with the business management firm, Gettleson, Witzer, and O’Connor, in Beverly Hills, California, where he focused on accounting and finance for several production studios generating motion picture releases and worldwide revenue that exceeded $1 billion. The firm’s clients included foundations, trusts, and independent actors, writers, producers and directors across the entertainment industry. While at the firm, he focused on budgeting, tax forecasting, and asset management. Earlier in his career, Mr. Bergmann served in financial positions in various industries. Mr. Bergmann graduated from Providence College with a Bachelor of Science degree in Management and a minor in Finance. He has an M.B.A. from the University of Southern California’s Marshall School of Business.

Session Details:

Working alongside your finance team from the clinical side to make your budget go further

2023-09-26, 3:00 PM

View In Agenda
Next speaker
Back
Ken Wilson
Outsourcing Lead, Pfizer

Ken has been in the industry for over 30 years, with just over 20 in the CRO world, at Quintiles, Statprobe, and Clinimetrics/Omnicare. Ken joined Pfizer in 2010 in an outsourcing role, and has been leading outsourcing efforts for multiple development programs. Experience prior to Pfizer includes hands-on and line management roles in Statistical Programming, Biostatistics, Data Management, and Project Management, as well as overall responsibility for a local CRO office in San Diego that employed more than 70 local employees.

Session Details:

Mining for Gold: Looking at trends and budget analysis to find cost savings

2023-09-27, 8:30 AM

View In Agenda
Next speaker
Back
Jiao Song
Director, Early Clinical Science

Session Details:

PANEL DISCUSSION – What are the lessons learned from decentralizing – what takeaways do we have as an industry from the last few years

2023-09-27, 1:45 PM

View In Agenda
Next speaker
Back
Tracy Lawhon
Chief Development Officer

Session Details:

Is Outsourcing Clinical Trials with Multiple Consultants Right for My Company? Balancing the Tradeoffs vs a Full Service CRO

2023-09-26, 4:30 PM

View In Agenda
Next speaker
Back
Ken Kobayashi
Senior Vice President

Experienced drug developer and executive with deep expertise across early and late development, multiple indications (including solid tumors and hematological malignancies), and drugs with many different mechanisms of action. Led highly successful global teams in US and AP regional teams while based in Japan. Moves easily between tactical/executional work at study team level and overall portfolio-level strategy and prioritization work at senior leadership level.”

Session Details:

PANEL DISCUSSION – What are the lessons learned from decentralizing – what takeaways do we have as an industry from the last few years

2023-09-27, 1:45 PM

Session Details:

PANEL DISCUSSION – Working closely with your site to achieve a mutually beneficial relationship

2023-09-27, 11:00 AM

View In Agenda
Next speaker
Back
Brandi Roberts
Chief Financial Officer

Brandi Roberts is the Executive Vice President and Chief Financial Officer at Longboard Pharmaceuticals (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Ms. Roberts has more than 25 years of public accounting and finance experience, including 22 years at publicly traded pharmaceutical, medical technology, and life science companies. Ms. Roberts is a certified public accountant with the State of California and received her B.S. degree in business administration from the University of Arizona and her M.B.A. from the University of San Diego.

Session Details:

PANEL DISCUSSION – Top tips and tricks for managing your trial budget during unstable times

2023-09-26, 2:00 PM

Session Details:

Dealing with Phase 3 data challenges; how to get data collection back on track

2023-09-26, 12:00 PM

View In Agenda
Next speaker
Back
Patty Law
Sr. Director, Clinical Affairs

Patty is currently the Head of Clinical Affairs for the Diagnostic Solutions Division at Hologic. Previous work experience includes serving as a Program Director for multiple CROs and as a Research Physiologist for the Naval Health Research Center.

Session Details:

IVD, Combining the regulatory & clinical strategy to improve clinical trial outcome

2023-09-27, 9:30 AM

View In Agenda
Next speaker
Back
Veronica Sandoval
Principal, Inclusion & Health Equity

Veronica Sandoval is a Principal in the Patient Inclusion and Health Equity team in the Chief Diversity Office (CDO) at Genentech. Veronica's policy and medical background, along with the personal and professional intersection of her Latino roots and health equity efforts, bring a rich perspective to Genentech’s ongoing work in health equity and inclusive research.

Veronica joined Roche-Genentech in 2018 as a Global Medical Collaboration Lead supporting the early clinical development program for autism. Prior to her role as Principal in the CDO, she supported the respiratory portfolio as a Medical Science Liaison. She has experience in health equity, medical affairs, thought leader development, patient engagement, and external partnerships. Therapeutic areas of expertise include ophthalmology, oncology, multiple sclerosis, immunology, asthma, inflammatory bowel disease, women’s health, autism spectrum disorder, idiopathic pulmonary fibrosis, and influenza. Veronica also practiced as an intellectual property litigation attorney focusing on complex patent litigation in the life sciences and pharmaceutical fields.

Veronica holds a Ph.D. in neuropharmacology from the University of Utah, a J.D. from Seattle University School of Law, and a B.A. in molecular and cell biology from the University of California, Berkeley.

Session Details:

KEYNOTE PANEL Patient engagement – What we as an industry need to do to promote trust

2023-09-26, 8:30 AM

View In Agenda
Next speaker
Back
Wendy Pizarro
, Chief Administrative Officer and Chief Legal Officer

Session Details:

KEYNOTE PANEL Patient engagement – What we as an industry need to do to promote trust

2023-09-26, 8:30 AM

Session Details:

The upcoming importance of diversity in clinical trials And how it can promote patient recruitment

2023-09-26, 2:00 PM

View In Agenda
Next speaker
Back
Kerry Clancy
Director of Outsourcing,
Next speaker
Back
Chad Orevillo
Vice President, Head of Operations

Session Details:

Finding CROs and partners as a small to medium sized company: challenges and considerations

2023-09-26, 12:00 PM

View In Agenda
Next speaker
Back
Prasun Mishra
Founding Partner, World Investors and Entrepreneurs Society

Dr Mishra (Ex Genentech, Ex NCI, Ex NIH) is the founding president and CEO of the American
Association for Precision Medicine ( and chair of ACT AAPM’s Coronavirus Taskforce He
is leading research efforts focused on preventing curing chronic diseases not only treating
the sick but also providing knowledge/tools to individuals to live longer, healthier lives

He is also the founder and CEO of Agility Pharmaceuticals, a pharmaceutical company
committed to revolutionizing drug discovery development through technology, big data,
robotics, and artificial intelligence He is a serial entrepreneur who founded his first company
after graduating high school, and his second company during his Ph D Since then, he has
accumulated a wealth of experience by building, investing, and advising numerous other
companies He is an investor, co founder/ board member of a few corporations, focused on
accelerating drug discovery/ development, data analytics, robotics, mental health, and digital
health He is also the founder of AAPM Angels and Investors AAi an investment group focused
on investing in drug discovery, diagnostics, precision medicine, technology healthcare
companies He is also the founding investor and advisor to Barcelona Ventures and serves as an
advisor to a 100 M private equity fund

Widely recognized as a thought leader in the field of ‘technology and healthcare’, Dr Mishra has
keynoted, chaired, curated, and organized numerous successful international conferences He
served as a Scientist and Principal Investigator at the pharma giant Genentech, Roche Where
he participated in several drug discovery project teams Moreover, his passion for drug
development and precision medicine has led to the identification of new drug targets,
biomarkers, companion diagnostics, and several drugs/ combinations in the clinic

His research work has been recognized globally by over 40 prestigious awards and honors Due
to his unique perspective selfless service, he is a highly respected sought after mentor to
many The companies that he has advised have raised multimillion dollars Notably, he serves
as a mentor and advisor to several VC funds and startup accelerators, including IndieBio
HIMSS/Health 2 0 ’s Project Zygote, MedLabs ZGC Capital, J&J JLabs UCSF Innovation Venture,
UCSF Invent Fund, and California Life Sciences’s FAST program, to help grow California’s life
sciences innovation ecosystem

Session Details:

Precision clinical trials in the era of big data, artificial intelligence, and precision medicine

2023-09-27, 12:15 PM

View In Agenda
Next speaker
Back
Barbara Birch
Associate Director, Clinical Procurement & Outsourcing

Session Details:

Navigating the perfect storm as a small biotech company: what you need to know to succeed

2023-09-26, 4:00 PM

View In Agenda
Next speaker
Back
Mirta Grifman
Vice President, Clinical Development and External Innovation

Session Details:

Interactive Workshop – Exploring the use of innovative technologies in clinical studies

2023-09-26, 3:00 PM

View In Agenda
Next speaker
Back
Emily Solomon
Vice President, Clinical Operations, Biosplice Therapeutics

Session Details:

Interactive Workshop – Exploring the use of innovative technologies in clinical studies

2023-09-26, 3:00 PM

View In Agenda
Next speaker
Back
Tanja Obradovic
Vice President, Scientific Affairs

Session Details:

KEYNOTE PANEL Patient engagement – What we as an industry need to do to promote trust

2023-09-26, 8:30 AM

Session Details:

Optimizing early development to maximize success probability in the late stage development

2023-09-26, 11:30 AM

View In Agenda
Next speaker
Back
Joseph Shan
Executive Director, Clinical Development Operations, MEI Pharma

Collaborative and outcome-based biopharmaceutical servant-leader providing 20+ years of clinical operations experience. Passionately advancing the mission of improving patients’ lives through timely and efficient execution of clinical trials. Adept at building and managing cross-functional teams comprising internal and/or external partners and CROs to meet the dynamic business needs of virtual start-ups to leading life science companies.

Next speaker

Plan Your Visit

Venue

Hyatt Regency La Jolla Aventine

3777 La Jolla Village Dr, San Diego, CA 92122, United States

Sponsors

Select a sponsor to learn more

FEATURED SPONSORS

SESSION SPONSORS

ASSOCIATE SPONSOR

DRINKS RECEPTION SPONSOR

TECHNOLOGY SHOWCASE SPONSOR

EXHIBITORS

CO-SPONSORS

Media Centre

MEDIA PARTNERS

Become A Media Partner

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Nick McCudden

Head of OCT Events

+61 280 978 126

SPEAKER ENQUIRIES

Douglas Webber

Conference Producer

+44 (0) 20 7866 9411

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact:

Nick McCudden

Head of OCT Events


+61 468 609 047

SPEAKER ENQUIRIES

To enquire about speaking opportunities for the conference, please contact:

Douglas Webber

Conference Producer


+44 (0) 20 7866 9411